Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Prepaid Assets: 2023-2024

Historic Prepaid Assets for Monte Rosa Therapeutics (GLUE) over the last 2 years, with Dec 2024 value amounting to $5.1 million.

  • Monte Rosa Therapeutics' Prepaid Assets fell 33.61% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 33.61%. This contributed to the annual value of $5.1 million for FY2024, which is 55.37% up from last year.
  • As of FY2024, Monte Rosa Therapeutics' Prepaid Assets stood at $5.1 million, which was up 55.37% from $3.3 million recorded in FY2023.
  • In the past 5 years, Monte Rosa Therapeutics' Prepaid Assets registered a high of $5.1 million during FY2024, and its lowest value of $3.3 million during FY2023.
  • Moreover, its 2-year median value for Prepaid Assets was $4.2 million (2023), whereas its average is $4.2 million.
  • Data for Monte Rosa Therapeutics' Prepaid Assets shows a peak YoY soared of 55.37% (in 2024) over the last 5 years.
  • Over the past 2 years, Monte Rosa Therapeutics' Prepaid Assets (Yearly) stood at $3.3 million in 2023, then surged by 55.37% to $5.1 million in 2024.